AUSTIN, Texas, Oct. 8, 2020 /PRNewswire-PRWeb/ -- We are pleased to announce the opening of our 6th site and 1st site within Los Angeles, Benchmark SoCal! Located in the central area of 11 Urgent Cares in the San Bernardino district, Benchmark SoCal has quickly been recognized for its integrity since opening having been awarded 2 Coronavirus studies and two diagnostic studies. The practice partnering with Benchmark in this inspiring venture has over 100,000 patient visits each year. The Principal Investigator for this location will be Dr. Brian Bearie who has over 21 years of experience in the medical field.
Benchmark Research was founded in 1997 by Mark Lacy, CEO and Scott Barrett, President. We have developed a track record of safety and expertise, having conducted more than 1,000 trials with 40,000+ participants. We work in partnership with the private and public sectors at clinics located in California, Louisiana and Texas to ensure you get safe and effective medications and vaccines.
In addition, Benchmark Research is a founding member within VaxCorps - a network of highly experienced, geographically diverse clinical research centers that have successfully conducted over 500 phase I-IV vaccine clinical trials, with extensive experience in seasonal and pandemic influenza as well as a vast array of other infectious and biodefense vaccine indications. Our integrity is recognized through the utmost quality and safety protocols that Benchmark Research adheres to. Our quality assurance program is guided by a former FDA investigator with extensive training experience and more than 30 years in the research industry at both site and industry levels. Benchmark maintains an active Clinical Trial Quality Plan that defines proactive procedures to ensure that all trials are compliant with ICH and GCP guidelines, FDA regulations, sponsor requirements, protocol requirements and Benchmark policies. The plan includes real-time, day to day observation and documentation of site work processes to ensure procedures are followed.
Benchmark Research - your partner in bringing your vaccines to market!
Contact Van Johnson – Executive Director of Business Development and Global Alliances for more information regarding partnerships - 469-854-0294 - [email protected]
SOURCE Benchmark Research